Navigation Links
Scientists discover the molecular switch for nerve cells' insulating jelly rolls

Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system. The study, published in the September 1, 2005, issue of the journal Neuron, may provide a new avenue for treating nervous system diseases such as multiple sclerosis, which are associated with damage to myelin.

A team led by James L. Salzer, M.D., Ph.D., Professor of Cell Biology and Neurology at NYU School of Medicine, identified the long-sought factor that determines whether or not nerve cells will be wrapped in thick layers of myelin, producing the biological equivalent of a jelly roll.

Using a sophisticated system for growing nerve cells in laboratory dishes, the team identified a gene called neuregulin as the myelin signal. This signal directs Schwann cells, the nervous system's cellular architects, to build elaborate sheaths of myelin around the axons of nerve cells. Axons are the long cable-like arms of nerve cells that send messages to other cells. The construction of myelin sheath has been called one of the most beautiful examples of cell specialization in nature.

Myelin forms the so-called white matter in the nervous system and constitutes 50 percent of the weight of the brain. It is also an important component of the spinal cord, and of nerves in other parts of the body. It has been known for almost 170 years that there are two kinds of axons --one is wrapped in myelin and appears white and the other is not and appears gray. Myelinated axons transmit messages in the nervous system up to 100 times faster than their unmyelinated cousins and are critical for proper neurological function. However, it wasn't known what actually initiated myelin production.

The neuregulin gene encodes a growth protein made by neurons. Last year a group of German scientists discove
'"/>

Source:New York University Medical Center and School of Medicine


Page: 1 2

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists decipher genome of fungus that can cause life-threatening infections
9. Scientists discover the cellular roots of graying hair
10. Scientists rid stem cell culture of key animal cells
11. Scientists develop new color-coded test for protein folding

Post Your Comments:
(Date:12/2/2009)...other foods have done more than raise public aware...quietly fueling a boom in the market for food test...tions. That,s the topic of the two-part cover stor...News , (C&EN) ACS, weekly newsmagazine. , C&EN A...ondent Marc Reisch point out that food safety is a...
(Date:12/2/2009)... you, at least if you are a mammal cell. , Resea...ogy Center have shown that in healthy cells, a bun...nucleus, its genetic storehouse, in its proper pla... nuclear shape, the researchers say, could provide...such as cancer, muscular dystrophy and the age-acc...
(Date:12/2/2009)... PALM HARBOR, Fla., Dec. 2 /PRNewswire-FirstCall/ ...(OTC Bulletin Board: CICI), a leading supplier of ...s automation in the financial industry* and the re...ion and Docubase Systems Inc. ("Docubase"), a lead...EDM) software provider announced today that they h...
Breaking Biology News(10 mins):A cell's 'cap' of bundled fibers could yield clues to disease 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 1Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 2Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 3Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 1Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 2ANAVEX reports sigma receptor review published in leading journal 55513 1ANAVEX reports sigma receptor review published in leading journal 55513 2ANAVEX reports sigma receptor review published in leading journal 55513 3
...of the amino acid supplement L-arginine following ...nctions and measurements and may be associated wit... in the January 4 issue of JAMA. , L-arginine is a...ized as having benefits for patients with hyperten..., according to background information in the artic...
...archers at Washington University School of Medicin...Salmonella to the short list of genes regulated by...almonella riboswitch is the first to sense and res...ypes of molecules that riboswitches can detect to ... , First identified in 2002, riboswitches sense w...
...archers at Virginia Commonwealth University,s Mass..., anti-cancer agent able to overcome acquired drug...bed into cancer cells and then attacking the DNA o...earchers design a new generation of anti-cancer dr...esistance and side effects and expand the range of...
Other Biology News:Little known DNA repair enzyme may be a tumor suppressor gene 2Salmonella bacteria use RNA to assess and adjust magnesium levels 2Salmonella bacteria use RNA to assess and adjust magnesium levels 3VCU Massey Cancer Center researchers identify a new class of anti-cancer drugs based on platinum 2
(Date:12/3/2009)...PRNewswire/ -- Nikon Corporation, an innovator of ... it has signed a licensing agreement with Harvard ...ochastic Optical Reconstruction Microscopy (STORM)...on will manufacture STORM enabled microscopy syste...ikon Corporation President, Mr. Michio Kariya, and...
(Date:12/3/2009)...PRNewswire-FirstCall/ -- Inverness Medical Innovat...ling individuals to take charge of their health at...health management, has declared a dividend of $3.0...Preferred Stock ( IMA-PB). The dividend will be pa...are equal to the quotient of (a) $3.00 divided by ...
(Date:12/2/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Neurostimulation - A Global Market Pe...4232/Neurostimulation---A-Global-Market-Perspectiv...tands enthused by the growing base of aging popula...es such as, Parkinson,s, and Alzheimer,s disease. ...
(Date:12/2/2009)... Peregrine Pharmaceutica...n of patient enrollment in a dose confirmation and...relapsed glioblastoma multiforme (GBM), the deadli...noclonal antibody linked to a radioisotope being d...tara specifically targets cells at the center of b...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...inancial times, good relationships with shareholde...itive relationship with current investors is espec...he best source for leading a companys next round o...t: , , Treat investors like customers! Understan...rtant in meeting their expectations. It is as impo...
...s of start-up and early-stage companies , ,In an...eadership, set business goals and prioritize steps...arly-stage companies, those activities must be acc...s their full, unwavering attention. Capital must b...erved. A business owner has to concentrate on deve...
...he University of Wisconsin-Stevens Point will rece...The WiSys Technology Foundation , an organization...Madison, has received notice from the U.S. Patent ... for a UW-Stevens Points (UWSP) associate professo...ssor of soils in UWSP s College of Natural Resour...
Other Biology Technology:Enhancing Relationships with Investors 2Management Perspectives: Outsource HR 2Management Perspectives: Outsource HR 3UW-Stevens Point Professor Receives Patent Approval For New Technology 2
Acridinium Quench Solution from Cayman Chemical
Mouse Anti-C3a / C3a des Arg Monoclonal Antibody, Unconjugated, Clone 2991 from Abcam
Rabbit Anti-NMDAR1 C2' Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-PI3K p110 delta (Poly6049) Polyclonal Antibody, Unconjugated from BioLegend
Biology Products: